American International Group, Inc. Oncocyte Corp Transaction History

American International Group, Inc.

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.86 - $1.53 $25,691 - $45,707	-29,874 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.15 - $2.25 $2,419 - $4,734	-2,104 Reduced 6.58%	29,874 $45,000
Q4 2021 Feb 11, 2022	SELL	$2.04 - $3.59 $1,950 - $3,432	-956 Reduced 2.9%	31,978 $69,000
Q3 2021 Nov 12, 2021	SELL	$3.53 - $5.89 $23,912 - $39,898	-6,774 Reduced 17.06%	32,934 $117,000
Q2 2021 Aug 13, 2021	SELL	$3.77 - $6.0 $6,910 - $10,998	-1,833 Reduced 4.41%	39,708 $228,000

Q1 2021 May 07, 2021	BUY	$2.39 - $6.5 $11,895 - $32,350	4,977 Added 13.61%	41,541 $216,000
Q4 2020 Feb 12, 2021	SELL	$1.38 - $2.63 $1,449 - $2,761	-1,050 Reduced 2.79%	36,564 $87,000
Q3 2020 Nov 04, 2020	BUY	$1.2 - $1.89 $13,388 - $21,086	11,157 Added 42.17%	37,614 $52,000
Q2 2020 Aug 12, 2020	BUY	$1.91 - $3.45 $25,231 - $45,574	13,210 Added 99.72%	26,457 $51,000
Q1 2020 May 04, 2020	SELL	$1.76 - $3.02 $374 - $643	-213 Reduced 1.58%	13,247 $32,000
Q4 2019 Feb 05, 2020	SELL	$1.51 - $2.27 $172 - $258	-114 Reduced 0.84%	13,460 $30,000
Q3 2019 Nov 08, 2019	SELL	$1.59 - $2.51 $149 - $235	-94 Reduced 0.69%	13,574 $29,000
Q2 2019 Aug 13, 2019	BUY	$2.49 - $5.45 $34,033 - $74,490	13,668 New	13,668 $34,000
Q2 2018 Aug 08, 2018	SELL	$2.0 - $3.3 $4,912 - $8,104	-2,456 Closed	0 $0
Q1 2018 May 07, 2018	SELL	$1.25 - $4.6 $165 - $607	-132 Reduced 5.1%	2,456 $5,000
Q4 2017 Feb 09, 2018	BUY	$3.9 - $7.4 $682 - $1,295	175 Added 7.25%	2,588 $12,000
Q3 2017 Nov 09, 2017	BUY	$4.55 - $7.55 $10,979 - $18,218	2,413	2,413 $18,000

1.16M

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $350M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.